Systemic effects of fluticasone nasal spray: Report of 2 cases

Endocrine Practice

Volumn 11, Issue 3, 2005, Pages 194-196

  Licata, Angelo A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE PLUS DIPHENOXYLATE; CORTICOSTEROID; CORTICOTROPIN; ESTRADIOL; ESTROGEN; FLUTICASONE; HYDROCORTISONE; LANSOPRAZOLE; LEVOTHYROXINE SODIUM; NOSE SPRAY; PREDNISONE; RISEDRONIC ACID; TETRACOSACTIDE; ANDROSTANE DERIVATIVE; ANTIALLERGIC AGENT; DRUG DERIVATIVE; ETIDRONIC ACID;

ADRENAL INSUFFICIENCY; ADULT; ARTICLE; BONE DENSITY; BONE INJURY; CASE REPORT; CLINICAL FEATURE; CORTICOTROPIN BLOOD LEVEL; DRUG USE; DRUG WITHDRAWAL; ESTROGEN THERAPY; FEMALE; HOSPITAL ADMISSION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; LABORATORY TEST; MEDICAL RECORD; PROVOCATION TEST; RETROSPECTIVE STUDY; ADDISON DISEASE; ADRENAL DISEASE; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HAY FEVER; INTRANASAL DRUG ADMINISTRATION; MIDDLE AGED; POSTMENOPAUSE OSTEOPOROSIS;

ADDISON DISEASE; ADMINISTRATION, INTRANASAL; ADRENAL GLAND DISEASES; ADRENOCORTICOTROPIC HORMONE; ANDROSTADIENES; ANTI-ALLERGIC AGENTS; BONE DENSITY; ESTROGEN REPLACEMENT THERAPY; ETIDRONIC ACID; FEMALE; HUMANS; HYDROCORTISONE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 27744453355     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.11.3.194     Document Type: Article

References (8)

1. Lane NE, Lukert B. The science and therapy of glucocorticoid-induced bone loss. Endocrinol Metab Clin North Am. 1998;27:465-483.
2. Kemp JP, Osur S, Shrewsbury SB, et al. Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial. Mayo Clin Proc. 2004;79:458-466.
3. Kaye TB. Effect of inhaled glucocorticoid, flunisolide, on bone mineral density: a 2-year prospective, controlled trial. Endocr Pract. 2000;6:311-317.
4. Eichenhorn MS, Wise RA, Madhok TC, et al (Lung Health Study Research Group). Lack of long-term adverse adrenal effects from inhaled triamcinolone: Lung Health Study II. Chest. 2003;124:57-62.
5. Wolthers OD. Systemic activity versus systemic adverse effects of nasal glucocorticoids in the treatment of allergic rhinitis. Acta Paediatr. 2000;89:1158-1161.
6. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med. 1999;159:941-955.
7. Brown PH, Blundell G, Greening AP, Crompton GK. Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids. Respir Med. 1990;85:501-510.
8. Manglik S, Flores E, Lubarsky L, Fernandez F, Chhibber VL, Tayek JA. Glucocorticoid insufficiency in patients who present to the hospital with severe sepsis: a prospective clinical trial. Crit Care Med. 2003;31:1668-1675.